Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir

Combination antiretroviral therapy (cART) is successfully used for prevention of perinatal HIV transmission. To investigate safety, we compared adverse events (AE) among infants exposed to different maternal cART regimens. We reviewed 158 HIV-uninfected infants born between 1997 and 2009, using logi...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Christiana, Weinberg, Adriana, Forster, Jeri E., Levin, Myron J., Davies, Jill, Pappas, Jennifer, Kinzie, Kay, Barr, Emily, Paul, Suzanne, McFarland, Elizabeth J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834394/
https://www.ncbi.nlm.nih.gov/pubmed/27127401
http://dx.doi.org/10.1155/2016/9848041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834394/
https://www.ncbi.nlm.nih.gov/pubmed/27127401
http://dx.doi.org/10.1155/2016/9848041

Ejemplares similares